EPOTHILONE AFFINITY LABELS
EPOTHILONE AFFINITY LABELS
批准号:
6513213
负责人:
Gunda I. Georg
金额:
$26.37万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-03-04 至 2004-02-29
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Anti-MT drugs continue to receive great interest for their
development as potential clinically useful antitumor agents. Several
new natural products with taxol-like activity towards tubulin and
microtubules have been identified recently. Of these, the epothiones
are the most promising and exciting. This group of compounds can be
isolated from bacterial source, making large scale production
feasible. Epothilone A and B have been shown to be equipotent to
taxol in stimulating tubulin assembly and competitively inhibiting
[3H]taxol binding to microtubules. The epothilones are also similar
to taxol in their anti-cell proliferative activity. However, these
compounds have much greater activity toward cells that are resistant
to taxol due to the over-expression of the P-glycoprotein multidrug
transporter or to the expression of an altered Beta-tubulin. Thus,
these compounds have the potential of overcoming two different
mechanisms of cell resistance to taxol.
Very little is known yet about the interaction of drugs with
microtubules. Such information would be useful for designing new and
better derivatives. Information obtained on the binding site will
also be extremely important for future work on the site directed
mutagenesis of the tubulin protein. A variety of approaches can be
taken to obtain this information, including those which we are
proposing, identification of peptides in the binding site through
photo affinity labeling and the use of fluorescence spectroscopy to
study detail of the interaction.
The results of the tubulin binding studies would suggest that the
binding sites for taxol and epothilone are identical. However, the
fact that the epothilones are effective cytotoxic agents in cells
that are resistant to taxol because of the expression of an altered
Beta-tubulin, indicates that the sites may be overlapping rather than
identical.
It is the plan to prepare epothilone affinity labels through
emisynthesis and total synthesis and evaluate them for tubulin
assembly activity and cytotoxicity. Fluorescent epothilones will be
used to study the interaction with microtubules and tubulin and the
epothilone photo affinity will identify the ligand binding sites in
the receptor.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Microbial Synthesis of Therapeutic Bile Acids for Alzheimer's Disease
-
批准号:10602316
-
项目类别:
-
资助金额:$134.42万
-
财政年份:2020
-
负责人:Gunda I. Georg
-
依托单位:
Drug Discovery & Synthesis of Contraceptive Agents
-
批准号:8530619
-
项目类别:
-
资助金额:$88.84万
-
财政年份:2012
-
负责人:Gunda I. Georg
-
依托单位:
Drug Discovery & Synthesis of Contraceptive Agents
-
批准号:9107483
-
项目类别:
-
资助金额:$84.64万
-
财政年份:2012
-
负责人:Gunda I. Georg
-
依托单位:
Drug Discovery & Synthesis of Contraceptive Agents
-
批准号:8700448
-
项目类别:
-
资助金额:$85.17万
-
财政年份:2012
-
负责人:Gunda I. Georg
-
依托单位:
Drug Discovery & Synthesis of Contraceptive Agents
-
批准号:8550538
-
项目类别:
-
资助金额:$84.14万
-
财政年份:2012
-
负责人:Gunda I. Georg
-
依托单位:
Drug Discovery & Synthesis of Contraceptive Agents
-
批准号:8551199
-
项目类别:
-
资助金额:$71.45万
-
财政年份:2012
-
负责人:Gunda I. Georg
-
依托单位:
Core - Drug, Discovery, Design and Synthesis
-
批准号:8152937
-
项目类别:
-
资助金额:$112.45万
-
财政年份:2010
-
负责人:Gunda I. Georg
-
依托单位:
CORE--Drug, Discovery, Design and Synthesis
-
批准号:8066373
-
项目类别:
-
资助金额:$44.28万
-
财政年份:2010
-
负责人:Gunda I. Georg
-
依托单位:
Libraries for HTS: Privileged Structures in Sparsely Populated Chemical Space
-
批准号:7676007
-
项目类别:
-
资助金额:$46.96万
-
财政年份:2007
-
负责人:Gunda I. Georg
-
依托单位:
Libraries for HTS: Privileged Structures in Sparsely Populated Chemical Space
-
批准号:7291334
-
项目类别:
-
资助金额:$45.24万
-
财政年份:2007
-
负责人:Gunda I. Georg
-
依托单位:
Libraries for HTS: Privileged Structures in Sparsely Populated Chemical Space
-
批准号:7490019
-
项目类别:
-
资助金额:$45.7万
-
财政年份:2007
-
负责人:Gunda I. Georg
-
依托单位:
COBRE: UKS: CORE C: MEDICINAL CHEMISTRY
-
批准号:7381084
-
项目类别:
-
资助金额:$34.48万
-
财政年份:2006
-
负责人:Gunda I. Georg
-
依托单位:
COBRE: UKS: CORE A: ADMINISTRATIVE CORE
-
批准号:7381082
-
项目类别:
-
资助金额:$42.92万
-
财政年份:2006
-
负责人:Gunda I. Georg
-
依托单位:
CORE--FIRST AWARD & EQUIPMENT & FACILITY SUPPORT
-
批准号:7170240
-
项目类别:
-
资助金额:$27.72万
-
财政年份:2005
-
负责人:Gunda I. Georg
-
依托单位:
COBRE: UKS: CORE A: ADMINISTRATIVE CORE
-
批准号:7170239
-
项目类别:
-
资助金额:$23.78万
-
财政年份:2005
-
负责人:Gunda I. Georg
-
依托单位:
CORE--MEDICINAL CHEMISTRY
-
批准号:7170242
-
项目类别:
-
资助金额:$29.96万
-
财政年份:2005
-
负责人:Gunda I. Georg
-
依托单位:
COBRE: UKS: CORE A: ADMINISTRATIVE CORE
-
批准号:7011656
-
项目类别:
-
资助金额:$24.92万
-
财政年份:2004
-
负责人:Gunda I. Georg
-
依托单位:
CORE--FIRST AWARD & EQUIPMENT & FACILITY SUPPORT
-
批准号:7011657
-
项目类别:
-
资助金额:$31.18万
-
财政年份:2004
-
负责人:Gunda I. Georg
-
依托单位:
COBRE: UKS: CORE D: MEDICINAL CHEMISTRY
-
批准号:7011659
-
项目类别:
-
资助金额:$22.56万
-
财政年份:2004
-
负责人:Gunda I. Georg
-
依托单位:
Tyloindicines: Chemistry and Biology
-
批准号:6438013
-
项目类别:
-
资助金额:$29.14万
-
财政年份:2002
-
负责人:Gunda I. Georg
-
依托单位: